MS clinical trial

  • Nov. 30, 2011 4:05 p.m.

Alberta Health and Wellness Minister Fred Horne welcomed news that the Canadian Institutes of Health Research is moving ahead with a request for research proposals for a clinical trial on Chronic Cerebrospinal Venous Insufficiency and multiple sclerosis.

“This is another important step to fill the evidence void that currently exists regarding the possible link between CCSVI and MS as well as the effectiveness of the Zamboni treatment,” said Horne, who attended meetings with federal, provincial and territorial health ministers in Halifax where the announcement was made.

“MS sufferers and their families want to know that governments are taking action to determine whether the treatment is safe and effective. This clinical trial, along with the current observational study underway in Alberta, will help us do that.”

Paolo Zamboni, a vascular surgeon, believes MS is not an auto-immune condition but a vascular disease he calls ‘chronic cerebrospinal venous insufficiency’ or CCSVI that can be corrected by surgery.

MS is described a chronic, often disabling disease of the brain and spinal cord. It is also the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and its unpredictable effects last for the rest of their lives.

Symptoms include vision disturbances, extreme fatigue, coordination problems, pain, depression, bladder and bowel problems and short term memory loss.

According to the MS Society, Canadians have one of the highest rates of multiple sclerosis in the world. MS is also the most common neurological disease affecting young adults in Canada. Every day, three more people in Canada are diagnosed with MS, and women are more than three times as likely to develop MS as men.

The Zamboni treatment, which is not approved for use in Canada, is being offered in other countries to treat CCSVI.

The Alberta Multiple Sclerosis Initiative (TAMSI) study includes a self-administered online survey, available at www.tamsi.ca that patients with MS or related conditions, once registered, will fill out at six, 12, 18 and 24-month intervals.

The study will match up anecdotal information with files from patients’ electronic health records from physician visits or medical tests. –

-Weber

Just Posted

Highland Games brings Scotland to Red Deer

71st annual event celebrates Scottish culture and heritage

Red Deer RCMP arrest man with imitation firearm

Man pointed firearm at several staff members before fleeing to a nearby restaurant

WATCH: Red Deer commemorates National Indigenous Peoples Day

Citizens take part in activities throughout the week

Red Deer RCMP investigate armed robbery at pharmacy

Suspect wielded a handgun, demanding staff member to open the safe

WATCH: Loads of summer events await Central Albertans

From CentreFest to Westerner Days, there will much to explore this season

Canadian Syrian children’s choir not to attend festival over fears about U.S. travel

Many kids are recent immigrants from countries covered by Trump travel ban

In a matter of hours, women in Saudi Arabia will be allowed to drive

Change was announced as a royal decree in 2017 by Crown Prince Mohammen bin Salman

COC session vote approves Calgary as potential host for 2026 Olympics

Scott Hutcheson, chair of Calgary’s Olympic bid corporation — called vote a positive step forward

Breaking: SuperNet provider Axia cannot guarantee continued service

Alberta’s health, schools, libraries, municipal governments at risk from delayed bidding

Ponoka County optimistic though cautious about tire recycling situation

New heavy-duty shredder on site, county hopeful this is a final solution

Research paper states low income earners hit hardest by dairy supply management

Canada’s poorest spend more of annual income on food staples than higher income earners

Sylvan Lake Legion honours the memory of past president

A new podium at the Legion was dedicated to Steve Dills at a recent meeting

Most Read